Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- ChiroTech Signs Exclusive Patent License Agreement With Massachusetts Institute of Technology
- LONDON--BW HealthWire--July 12, 1999--
- Research articles 1999-07-12
- Cheung Laboratories Inc., CLI, enters into an exclusive license agreement for three MIT patents to be used for cancer treatment
- COLUMBIA, Md.--BUSINESS WIRE--June 12, 1996--CLI (OTC BB:CGLB) has entered into an exclusive license agreement with Massachusetts Institute of Technology MIT for the commercialization rights to a proprietary patented Adaptive Phased Array APA technology to be used in conjunction with CLI's hyperthermia systems for the treatment of cancer.
- Research articles 1996-06-12
- Bayer AG, Leverkusen and Rodia ChiRex Inc have signed license agreements with the Massachusetts Institute of Technology (MIT), US.(Brief Article)
- Bayer AG, Leverkusen, and Rodia ChiRex Inc have signed license agreements with the Massachusetts Institute of Technology MIT, US. These agreements are for the development of catalytic ... Bayer AG, Leverkusen, and Rodia ChiRex Inc have signed license agreements with the Massachusetts Institute of Technology MIT,...
- Research articles 2002-08-15
Additional Resources
- Corning Signs Licensing Agreement with Whitehead Institute and Massachusetts Institute of Technology; Demonstrates Commitment to Developing and Delivering Innovative New Technologies to the Life Science Marketplace
- CORNING, N.Y. -- Corning Incorporated (NYSE: GLW) announced today it has signed a patent license agreement with the Whitehead Institute through Massachusetts Institute of Technology MIT, its licensing agent. Under terms of the agreement, Whitehead Institute for Biomedical Research has granted Corning a license for patent rights to Reverse Transfection...
- Research articles 2005-08-03
- Cambridge Heart Licenses Technology from Massachusetts Institute of Technology
- Patent Covers Measurement of T-Wave Alternans from Implantable Devices TEWKSBURY, Mass. -- Cambridge Heart, Inc. (OTCBB: CAMH), today announced that it has licensed United States Patent 7,336,995 "Method and Apparatus for Tachycardia Detection and Treatment" from the Massachusetts Institute of Technology MIT under the terms of its umbrella technology...
- Research articles 2008-06-23
- Network Plus, MIT Enter Into 20-Year Fiber Agreement; Allows Network Plus to Complete OC-48 SONET Ring
- QUINCY, Mass.--BUSINESS WIRE--Nov. 15, 1999-- Network Plus Corp (NASDAQ:NPLS) has announced the signing of a twenty-year license agreement with the Massachusetts Institute of Technology MIT in Cambridge, Massachusetts, to run cable through a portion of a conduit facility on that campus which will inter-link two Bell Atlantic conduit systems....
- Research articles 1999-11-15
- MIT and T-Ray Science Conclude IP Agreement
- T-Ray Science, Inc. ("T-Ray", the "Company"), an emerging leader in the field of TeraHertz ("THz") research, today announced an exclusive patent license agreement has been reached with the Massachusetts Institute of Technology ("MIT"). The license grants T-Ray the exclusive right to produce spectroscopy and imaging systems which utilize dual-mode, pulsed...
- Research articles 2008-10-14
- ImmunoTherapeutics Receives Option for Oral Drug Delivery Technology
- FARGO, N.D.--BUSINESS WIRE--Aug. 29, 1996-- ImmunoTherapeutics, Inc. (OTC Bulletin Board: IMNP) today announced the receipt of an option agreement from the Massachusetts Institute of Technology ("MIT"). Under the agreement, ImmunoTherapeutics has an exclusive opportunity to negotiate a license to patent applications relating to the use of polymerized liposomes for...
- Research articles 1996-08-29
- Compaq & Seagate Sued For $800 Million - Company Business and Marketing
- Convolve Inc. announced that it and the Massachusetts Institute of Technology MIT, as obligated through its license agreement with Convolve, filed a lawsuit against Compaq Computer Corp. and Seagate Technology Inc. in the US District Court Southern District of New York, which according to the complaint, seeks "to prevent Compaq...
- Research articles 2000-07-24
- Cheung Laboratories Inc. appoints Verle D. Blaha as acting president and chief executive officer
- COLUMBIA, Md.--BUSINESS WIRE--Sept. 6, 1996--Cheung Laboratories Inc. CLI (OTC BB:CGLB) announced Friday that its board of directors has appointed Verle D. Blaha as acting president and chief executive officer to implement CLI's new business plan to develop and commercialize several recently-acquired patented technologies.On June 12, 1996, CLI entered into an...
- Research articles 1996-09-06
- Arch Therapeutics Licenses Groundbreaking Intellectual Property on Hemostasis
- Compositions That Stop Bleeding Promptly Could Revolutionize Surgical and Trauma Markets CAMBRIDGE, Mass. -- Arch Therapeutics, a life science company developing and commercializing compositions that promptly stop or control bleeding, today announced it has finalized a license agreement with the Massachusetts Institute of Technology. The license provides Arch...
- Research articles 2008-04-28
- << Previous
- page 1 of 1
- Next >>
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
